Genetic risk factors for type 1 diabetes (Q28276356)

Year in diabetes 2012: The diabetes tsunami

Europe PubMed Central

title

Genetic risk factors for type 1 diabetes (English)

0 references

0 references

2

0 references

Flemming Pociot

object named as

Flemming Pociot

series ordinal

1

0 references

language of work or name

English

0 references

publication date

4 June 2016

0 references

published in

The Lancet

0 references

volume

387

0 references

issue

10035

0 references

page(s)

2331-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Patterns of β-cell autoantibody appearance and genetic associations during the first years of life

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Environmental triggers of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Prospective assessment in newborns of diabetes autoimmunity (PANDA): maternal understanding of infant diabetes risk

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Population-wide infant screening for HLA-based type 1 diabetes risk via dried blood spots from the public health infrastructure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Screening for genetic IDDM risk and prevention trials in infancy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Next generation sequencing reveals the association of DRB3*02:02 with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Prediction and interaction in complex disease genetics: experience in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Genetics of diabetes--are we missing the genes or the disease?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Annotation of functional variation in personal genomes using RegulomeDB

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Effects of GWAS-associated genetic variants on lncRNAs within IBD and T1D candidate loci

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

IL-27-induced modulation of autoimmunity and its therapeutic potential

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

IL-27 Inhibits Hyperglycemia and Pancreatic Islet Inflammation Induced by Streptozotocin in Mice

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

The pathogenic role of interleukin-27 in autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

BH3-only proteins: a 20-year stock-take

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Dual role of proapoptotic BAD in insulin secretion and beta cell survival

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Effects of glucokinase activators GKA50 and LY2121260 on proliferation and apoptosis in pancreatic INS-1 beta cells

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Is CD69 an effective brake to control inflammatory diseases?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

The diabetes susceptibility gene Clec16a regulates mitophagy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Systems biology of asthma and allergic diseases: a multiscale approach

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY)

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Influence of Intensive versus Conventional Glucose Control on Microvascular and Macrovascular Complications in Type 1 and 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

The genetics of diabetic complications

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

Genetic insights into common pathways and complex relationships among immune-mediated diseases

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(16)30582-7

7 January 2021

10.1016/S0140-6736(16)30582-7

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

27302272

1 reference

Consolidated OpenCitations Corpus – April 2017